{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:05:43Z","timestamp":1792242343257,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00210-020-01838-w","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T01:15:00Z","timestamp":1582161300000},"page":"1391-1404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation"],"prefix":"10.1007","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-7622","authenticated-orcid":false,"given":"Eman","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman","family":"Essmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona F.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr A. A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"key":"1838_CR1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1464-5491.2006.01943.x","volume":"23","author":"S Ali","year":"2006","unstructured":"Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23:1165\u20131173","journal-title":"Diabet Med"},{"key":"1838_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12640-013-9454-8","volume":"26","author":"L Antkiewicz-Michaluk","year":"2014","unstructured":"Antkiewicz-Michaluk L, W\u0105sik A, Mo\u017cd\u017ce\u0144 E, Roma\u0144ska I, Michaluk J (2014) Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat. Neurotox Res 26:85\u201398","journal-title":"Neurotox Res"},{"key":"1838_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cbi.2016.08.016","volume":"258","author":"NM Arafa","year":"2016","unstructured":"Arafa NM, Marie MA, AlAzimi SA (2016) Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model. Chem Biol Interact 258:79\u201388","journal-title":"Chem Biol Interact"},{"key":"1838_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","volume":"64","author":"AE Autry","year":"2012","unstructured":"Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64:238\u2013258","journal-title":"Pharmacol Rev"},{"key":"1838_CR5","doi-asserted-by":"crossref","first-page":"e76786","DOI":"10.1371\/journal.pone.0076786","volume":"8","author":"MC Calixto","year":"2013","unstructured":"Calixto MC, Lintomen L, Andre DM, Leiria LO, Ferreira D, Lellis-Santos C, Anhe GF, Bordin S, Landgraf RG, Antunes E (2013) Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS One 8:e76786","journal-title":"PLoS One"},{"key":"1838_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/NDT.S121149","volume":"13","author":"R Colle","year":"2017","unstructured":"Colle R, de Larminat D, Rotenberg S, Hozer F, Hardy P, Verstuyft C, F\u00e8ve B, Corruble E (2017) Pioglitazone could induce remission in major depression: a meta-analysis. Neuropsychiatr Dis Treat 13:9\u201316","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1838_CR7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","volume":"4","author":"SC Cork","year":"2015","unstructured":"Cork SC, Richards JE, Holt MK, Gribble FM, Reimann F, Trapp S (2015) Distribution and characterisation of glucagon-like peptide-1 receptor expressing cells in the mouse brain. Molec Metabol 4:718\u2013731","journal-title":"Molec Metabol"},{"key":"1838_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/occmed\/kqm105","volume":"58","author":"MP Cosgrove","year":"2007","unstructured":"Cosgrove MP, Sargeant LA, Griffin SJ (2007) Does depression increase the risk of developing type 2 diabetes? Occup Med 58:7\u201314","journal-title":"Occup Med"},{"key":"1838_CR9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004714-199610000-00003","volume":"16","author":"NJ Coupland","year":"1996","unstructured":"Coupland NJ, Bell CJ, Potokar JP (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16:356\u2013362","journal-title":"J Clin Psychopharmacol"},{"key":"1838_CR10","doi-asserted-by":"crossref","unstructured":"Dong XZ, Wang DX, Lu YP, Yuan S, Liu P, Hu Y (2017) Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats. Braz J Med Biol Res 50(10):e6161","DOI":"10.1590\/1414-431x20176161"},{"key":"1838_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejphar.2015.11.033","volume":"769","author":"MM El Batsh","year":"2015","unstructured":"El Batsh MM, Manal M, Shafik NM, Younos IH (2015) Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats. Eur J Pharmacol 769:297\u2013305","journal-title":"Eur J Pharmacol"},{"key":"1838_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.brainresbull.2018.01.001","volume":"137","author":"MH Esmaeili","year":"2018","unstructured":"Esmaeili MH, Bahari B, Salari AA (2018) ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer\u2019s disease. Brain Res Bull 137:265\u2013276","journal-title":"Brain Res Bull"},{"key":"1838_CR13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","volume":"246","author":"JC Felger","year":"2013","unstructured":"Felger JC, Lotrich FE (2013) Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246:199\u2013229","journal-title":"Neuroscience"},{"key":"1838_CR14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bmj.330.7488.396","volume":"330","author":"D Fergusson","year":"2005","unstructured":"Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330:396","journal-title":"BMJ"},{"key":"1838_CR15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0891-5849(96)00501-1","volume":"22","author":"L Floh\u00e9","year":"1997","unstructured":"Floh\u00e9 L, Brigelius-Floh\u00e9 R, Saliou C, Traber MG, Packer L (1997) Redox regulation of NF-kappa B activation. Free Radic Biol Med 22:1115\u20131126","journal-title":"Free Radic Biol Med"},{"key":"1838_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2005.04.032","volume":"383","author":"P Gan","year":"2005","unstructured":"Gan P, Cheng JS, Ng YK, Ling EA (2005) Role of GABA in electro-acupuncture therapy on cerebral ischemia induced by occlusion of the middle cerebral artery in rats. Neurosci Lett 383:317\u2013321","journal-title":"Neurosci Lett"},{"key":"1838_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11920-996-0012-4","volume":"2","author":"AJ Gelenberg","year":"2000","unstructured":"Gelenberg AJ, Delgado P, Nurnberg HG (2000) Sexual side effects of antidepressant drugs. Curr Psychiatry Rep 2:223\u2013227","journal-title":"Curr Psychiatry Rep"},{"key":"1838_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10401230109147127","volume":"13","author":"PJ Goodnick","year":"2001","unstructured":"Goodnick PJ (2001) Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 13:31\u201341","journal-title":"Ann Clin Psychiatry"},{"key":"1838_CR19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","volume":"41","author":"M Guo","year":"2014","unstructured":"Guo M, Mi J, Jiang QM, Xu JM, Tang YY, Tian G, Wang B (2014) Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharmacol Physiol 41:650\u2013656","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1838_CR20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbi.2014.06.200","volume":"42","author":"C Hoyo-Becerra","year":"2014","unstructured":"Hoyo-Becerra C, Schlaak JF, Hermann DM (2014) Insights from interferon-alpha-related depression for the pathogenesis of depression associated with inflammation. Brain Behav Immun 42:222\u2013231","journal-title":"Brain Behav Immun"},{"key":"1838_CR21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pnpbp.2014.01.016","volume":"51","author":"L Hritcu","year":"2014","unstructured":"Hritcu L, Gorgan LD (2014) Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus. Prog Neuro-Psychopharmacol Biol Psychiatry 51:126\u2013132","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1838_CR22","first-page":"293","volume":"25","author":"Q-j Huang","year":"2004","unstructured":"Huang Q-j, Jiang H, Hao X-l, Minor TR (2004) Brain IL-1beta was involved in reserpine-induced behavioral depression in rats. Acta Pharmacol Sin 25:293\u2013296","journal-title":"Acta Pharmacol Sin"},{"key":"1838_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.psychres.2017.10.008","volume":"259","author":"S Ishijima","year":"2018","unstructured":"Ishijima S, Baba H, Maeshima H, Shimano T, Inoue M, Suzuki T, Arai H (2018) Glucocorticoid may influence amyloid \u03b2 metabolism in patients with depression. Psychiatry Res 259:191\u2013196","journal-title":"Psychiatry Res"},{"key":"1838_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1358\/dnp.2010.23.4.1437710","volume":"23","author":"RK Kaundal","year":"2010","unstructured":"Kaundal RK, Sharma SS (2010) Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents. Drug News Perspect 23:241\u2013256","journal-title":"Drug News Perspect"},{"key":"1838_CR25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","volume":"62","author":"K Labuzek","year":"2010","unstructured":"Labuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopien B (2010) Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep 62:956\u2013965","journal-title":"Pharmacol Rep"},{"key":"1838_CR26","doi-asserted-by":"crossref","first-page":"e0134476","DOI":"10.1371\/journal.pone.0134476","volume":"10","author":"C Lahmann","year":"2015","unstructured":"Lahmann C, Kramer HB, Ashcroft FM (2015) Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents. PLoS One 10:e0134476","journal-title":"PLoS One"},{"key":"1838_CR27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.intimp.2017.05.036","volume":"49","author":"L Liao","year":"2017","unstructured":"Liao L, Zhang X, Li J, Zhang Z, Yang C, Rao C, Zhou C, Zeng L, Zhao L, Fang L (2017) Pioglitazone attenuates lipopolysaccharide-induced depression-like behaviors, modulates NF-\u03baB\/IL-6\/STAT3, CREB\/BDNF pathways and central serotonergic neurotransmission in mice. Int Immunopharmacol 49:178\u2013186","journal-title":"Int Immunopharmacol"},{"key":"1838_CR28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/bmj.326.7397.1014","volume":"326","author":"S MacGillivray","year":"2003","unstructured":"MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I (2003) Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 326:1014","journal-title":"BMJ"},{"key":"1838_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2010.11.007","volume":"52","author":"SM Markowitz","year":"2011","unstructured":"Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA (2011) A review of treating depression in diabetes: emerging findings. Psychosomatics 52:1\u201318","journal-title":"Psychosomatics"},{"key":"1838_CR30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1838_CR31","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.2174\/1381612821666150710145753","volume":"21","author":"JM Meneses","year":"2015","unstructured":"Meneses JM, Silva MB, Sousa M, Sa R, Oliveira FP, Alves GM (2015) Antidiabetic drugs: mechanisms of action and potential outcomes on cellular metabolism. Curr Pharm Des 21:3606\u20133620","journal-title":"Curr Pharm Des"},{"key":"1838_CR32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phymed.2017.10.014","volume":"37","author":"RP Nankar","year":"2017","unstructured":"Nankar RP, Doble M (2017) Hybrid drug combination: anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone. Phytomedicine 37:4\u20139","journal-title":"Phytomedicine"},{"key":"1838_CR33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jdiacomp.2007.09.001","volume":"23","author":"NK Nazaroglu","year":"2009","unstructured":"Nazaroglu NK, Sepici-Dincel A, Altan N (2009) The effects of sulfonylurea glyburide on superoxide dismutase, catalase, and glutathione peroxidase activities in the brain tissue of streptozotocin-induced diabetic rat. J Diabetes Complicat 23:209\u2013213","journal-title":"J Diabetes Complicat"},{"key":"1838_CR34","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.bcp.2012.09.025","volume":"84","author":"CS Park","year":"2012","unstructured":"Park CS, Bang BR, Kwon HS, Moon KA, Kim TB, Lee KY, Moon HB, Cho YS (2012) Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem Pharmacol 84:1660\u20131670","journal-title":"Biochem Pharmacol"},{"key":"1838_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-12-0521","volume":"218","author":"H Pintana","year":"2013","unstructured":"Pintana H, Apaijai N, Chattipakorn N, Chattipakorn SC (2013) DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. J Endocrinol 218:1\u201311","journal-title":"J Endocrinol"},{"key":"1838_CR36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"1838_CR37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0253-7613.150305","volume":"47","author":"V Prabhakar","year":"2015","unstructured":"Prabhakar V, Gupta D, Kanade P, Radhakrishnan M (2015) Diabetes-associated depression: the serotonergic system as a novel multifunctional target. Indian J Pharm 47:4","journal-title":"Indian J Pharm"},{"key":"1838_CR38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/dme.12822","volume":"33","author":"K R\u00e5dholm","year":"2016","unstructured":"R\u00e5dholm K, Wir\u00e9hn AB, Chalmers J, \u00d6stgren CJ (2016) Use of antidiabetic and antidepressant drugs is associated with increased risk of myocardial infarction: a nationwide register study. Diabet Med 33:218\u2013223","journal-title":"Diabet Med"},{"key":"1838_CR39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ddr.21324","volume":"77","author":"R Refaat","year":"2016","unstructured":"Refaat R, Sakr A, Salama M, El Sarha A (2016) Combination of vildagliptin and pioglitazone in experimental type 2 diabetes in male rats. Drug Dev Res 77:300\u2013309","journal-title":"Drug Dev Res"},{"key":"1838_CR40","doi-asserted-by":"crossref","unstructured":"Rotella F, Mannucci E (2013) Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 74(1):31\u201337","DOI":"10.4088\/JCP.12r07922"},{"key":"1838_CR41","doi-asserted-by":"crossref","unstructured":"Roy T, Lloyd CE (2012) Epidemiology of depression and diabetes: a systematic review. J Affect Disord 142(Suppl):S8\u2013S21","DOI":"10.1016\/S0165-0327(12)70004-6"},{"key":"1838_CR42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1871530315666150316124019","volume":"15","author":"Y Saisho","year":"2015","unstructured":"Saisho Y (2015) Metformin and inflammation: its potential beyond glucose-lowering effect. Endocr Metab Immune Disord Drug Targets 15:196\u2013205","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1838_CR43","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J, Collaboration ERF (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215\u20132222","journal-title":"Lancet"},{"key":"1838_CR44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11011-017-0017-1","volume":"32","author":"J-D Shen","year":"2017","unstructured":"Shen J-D, Wei Y, Li Y-J, Qiao J-Y, Li Y-C (2017) Curcumin reverses the depressive-like behavior and insulin resistance induced by chronic mild stress. Metab Brain Dis 32:1163\u20131172","journal-title":"Metab Brain Dis"},{"key":"1838_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2017.08.019","volume":"1674","author":"N Shivavedi","year":"2017","unstructured":"Shivavedi N, Kumar M, Tej G, Nayak PK (2017) Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats. Brain Res 1674:1\u20139","journal-title":"Brain Res"},{"key":"1838_CR46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2017.03.399","volume":"255","author":"Y-J Shyong","year":"2017","unstructured":"Shyong Y-J, Wang M-H, Kuo L-W, Su C-F, Kuo W-T, Chang K-C, Lin F-H (2017) Mesoporous hydroxyapatite as a carrier of olanzapine for long-acting antidepression treatment in rats with induced depression. J Control Release 255:62\u201372","journal-title":"J Control Release"},{"key":"1838_CR47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-61779-111-6_2","volume-title":"Neuroproteomics","author":"S Spijker","year":"2011","unstructured":"Spijker S (2011) Dissection of rodent brain regions. In: Li KW (ed) Neuroproteomics. Humana Press, Totowa, pp 13\u201326"},{"key":"1838_CR48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12974-017-0985-4","volume":"14","author":"WJ Su","year":"2017","unstructured":"Su WJ, Peng W, Gong H, Liu YZ, Zhang Y, Lian YJ, Cao ZY, Wu R, Liu LL, Wang B, Wang YX, Jiang CL (2017) Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance. J Neuroinflammation 14:210","journal-title":"J Neuroinflammation"},{"key":"1838_CR49","first-page":"274986","volume":"2013","author":"L Wang","year":"2013","unstructured":"Wang L, Duan G, Lu Y, Pang S, Huang X, Jiang Q, Dang N (2013) The effect of simvastatin on glucose homeostasis in streptozotocin induced type 2 diabetic rats. J Diabetes Res 2013:274986","journal-title":"J Diabetes Res"},{"key":"1838_CR50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2016.11.036","volume":"637","author":"M Ye","year":"2017","unstructured":"Ye M, Ke Y, Liu B, Yuan Y, Wang F, Bu S, Zhang Y (2017) Root bark of Morus alba ameliorates the depressive-like behaviors in diabetic rats. Neurosci Lett 637:136\u2013141","journal-title":"Neurosci Lett"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-020-01838-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T16:49:33Z","timestamp":1722444573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-020-01838-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1007\/s00210-020-01838-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were conducted in accordance with the accepted principles for care and use of laboratory animals and were approved by the animal ethics committee of Faculty of Pharmacy, Zagazig University, Egypt (Approval number: P1-12-2017).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}